Gene therapy reprograms the tumor microenvironment

dna1

The tumor builds around itself a "wall" of immunosuppressive cells or physical and chemical factors that seal off or weaken immune cells. Researchers managed to “hack” and reprogram the tumor microenvironment (TME) using a special “Trojan Horse”. A gene making IFNα was inserted in a cell population within the tumor, imposing an immunostimulatory program to the TME.

Nanobodies: A lesson learned from camels and sharks

virus oncolitico

Isn’t it ironic that members of the camelid family (camels, llamas, dromedaries) or sharks that are so bigger than we are, present antibodies that are smaller than ours? Just as curious is that these “miniature antibodies” first detected in 1993 are very interesting for a number of biotechnological applications and scientists think that they could lead to drugs for cancer and other diseases.

Oncolytic viruses and immunotherapy: the perfect match

virus oncolitico

We are used to considering viruses as enemies, tending to forget the multitude of their other applications in biotechnology and biomedicine. For one thing, did you know that viruses could be weapons against cancer cells? In fact, that is precisely what oncolytic viruses are used for. Moreover, a review recently published on Nature Immunology explores their possible combination with other anti-neoplastic agents and especially with cancer immunotherapy. Viruses and immune system: two sworn enemies that somehow work “together” against tumour cells.

Veterinary Immunotherapy and Translational Research

Contacts

  • E-Mail:

    This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Veterinary Immunotherapy and Translational Research
  • C.F. 96451790586

VITARES
© Copyright 2022
All rights reserved